Kura Oncology, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| KURA | AKTS | AVBP | BBOT | SNDX | ORIC | |
|---|---|---|---|---|---|---|
| Market cap | 676.99M | 845.42M | 665.16M | 184.40M | 940.80M | 968.12M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -3.2 | -7.1 | -3.6 | -0.8 | -14.4 | -5.5 |
| Price/book | 14.0 | 1.7 | 1.8 | 0.6 | -54.7 | 2.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −0.60% | −33.30% | −28.97% | −81.29% | −5.36% | −22.54% |
| Today | −22.98% | +1.74% | +3.61% | −0.86% | −26.87% | −2.61% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All KURA news ›Kura Oncology (NASDAQ:KURA) Stock Falls 12% – Here’s What Happened
Posted by Sarita Garza on Nov 4th, 2026 Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) shares were down 12% on Wednesday. The stock traded as low as $8.89 and last traded at $8.6910. Approximately 572,242 shares were traded during…
Kura Oncology (KURA) Expected to Release Earnings on Tuesday
Posted by Defense World Staff on Nov 1st, 2026 Read Our Latest Stock Analysis on Kura Oncology Kura Oncology, Inc (NASDAQ: KURA) is a biopharmaceutical company focused on developing precision medicines for the treatment of cancer. The…
Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML
Stock quotes, market indicators and the latest market news. Ziftomenib was approved by the U.S. Food and Drug Administration (FDA) in November 2025 for the treatment of adult patients with R/R NPM1-m AML who have no satisfactory…
Traditional Chinese Formula Chuining Slows Pituitary Tumor Growth by Suppressing KIF20B
A traditional Chinese medicine formula known as Chuining formula (CNF) appears to fight pituitary tumors by promoting cancer cell death and cutting off their glucose supply, according to a new study published in Biological Procedures…
Promising role of antidiabetic drug in cancer control
Flinders University researchers have analysed how an antidiabetic treatment could help control the growth of tumours, potentially paving the way for the design of better cancer treatments. The new study investigated what happens when…
Kura forms Lilly-backed spinout with $50m to develop diabetes drug
San Diego-based Kura Oncology has carved out a new company, Caspian Therapeutics, to push a diabetes drug candidate toward the clinic. The spinout arrives with $50 million in financing led by BVF Partners. Other investors in the round…
KURE Corp. Completes $4.7 Million Second Round of Funding; Expansion Capital to Fuel Growth of Its Unique Vaporium Lounges
CHARLOTTE, N.C., June 1, 2015 /PRNewswire/ -- KURE Corp., one of the fastest growing companies in the vape and e-cigarette industry in the United States, announces the completion of $4.7 million in ... CHARLOTTE, N.C., June 1, 2015…
Reviewing Kura Oncology (NASDAQ:KURA) and Immatics (NASDAQ:IMTX)
Posted by Michael Walen on Oct 22nd, 2026 Immatics (NASDAQ:IMTX – Get Free Report) and Kura Oncology (NASDAQ:KURA – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two…
Knight Therapeutics signs exclusive distribution agreement with Kyowa Kirin
Knight Therapeutics (KHTRF) announced the signing of an exclusive distribution agreement with Kyowa Kirin International, a wholly owned subsidia... Knight Therapeutics signs exclusive distribution agreement with Kyowa Kirin Knight…
KRKA Pharma Private Limited announced that it expects to receive INR 2.22575082 billion in funding from Laurus Labs Limited, Krka, d. d.
KRKA Pharma Private Limited announced that it will issue equity share for the gross proceeds INR 2,225,750,820 on April 30, 2026. The transaction will include participation from returning investor... KRKA Pharma Private Limited announced…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- themarketsdaily.com3
- defenseworld.net2
- globenewswire.com2
- bioxconomy.com1
- freepressjournal.in1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.